
Reduction in ins-7 gene expression in non-neuronal cells of high glucose exposed Caenorhabditis elegans protects from reactive metabolites, preserves neuronal structure and head motility, and prolongs lifespan
Keywords: AGE; advanced glycation end-product; AU; arbitrary units; C. elegans; Caenorhabditis elegans; ctrl; control; DAF; abnormal dauer formation; DN; diabetic neuropathy; E. coli; Escherichia coli; FCCP; carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone; FOX